Participant flow
Eighty individuals were referred for screening, 21 (26%) and 6 (8%) of whom were excluded prior to and following attendance at the formal eligibility assessment, respectively. The remaining 53 (66%) individuals entered the randomized treatment portion of the trial and were included in analyses; 23 (43%) and 30 (57%) were allocated to MVC+OBT and OBT, respectively. The flowchart and reasons for participant exclusion are shown in 